Condition: Germ Cell Tumor · Non-seminomatous Germ Cell Tumor · Ovarian Germ Cell Tumor · Sponsor: Nabil Adra
This is an open label randomized phase II trial of maintenance oral etoposide vs. observation in patinets with relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT).
This description comes directly from the study's public registry record.
Christin Snow, RN · 317-274-5830 · chsnow@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University Melvin & Bren Simon Cancer Center | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04804007